Zaigle자이글

Zaigle remains loss-making with shrinking revenue, and its recent filings point to a corporate review and a delisting process.

Zaigle sells wellness kitchen appliances and medical devices in South Korea, with production outsourced to contract factories in China. For the trailing twelve months to H1 2026 it reported revenue of about ₩9.2B, an operating loss of about ₩1.3B and a net loss of about ₩1.8B, with borrowings of ₩30.6B against cash of ₩0.6B. The recent filing list includes several delisting-related notices and a corporate review committee result.

What stands out

• Trailing revenue is about ₩9.2B, down from ₩12.1B in 2024 and ₩8.2B in 2025 on a calendar basis, while losses have narrowed from 2025 levels but remain large (operating margin -14.1%, net margin -19.8%).
• Free cash flow over the trailing period was about -₩7.9B, and liabilities are 159% of equity, which the data flags as a financial strain.
• Several filings in September and October 2026 are titled Delisting, alongside an announcement of corporate review committee results and a submitted improvement plan.
• Shares closed at ₩5,310 near the 52-week low of ₩5,290 and about 4.3% below a year earlier, with no dividend.
• Foreign ownership is 0.5% and unchanged over 60 days, and the latest news headline in the data does not concern Zaigle.

What to watch

• Whether the delisting-related filings lead to a formal decision, and what the corporate review committee outcome means for listing status.
• Progress on the submitted improvement plan and whether the company reports any changes to its borrowings or cash position.
• The next periodic results, since the data does not include a forecast or any analyst estimates for future earnings.